U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"What, sir, would you make a ship sail against the wind and currents by lighting a bonfire under her deck? I pray you, excuse me, I have not the time to listen to such nonsense."

Napoleon Bonaparte ; When told of the Robert Fulton steamboat

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/296 - Plural chalcogens bonded directly to ring carbons of the six-membered hetero ring


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds containing at least two chalcogens (i.e., oxygens,
No. of applications: 86
Last issue date: 05/02/2013


  2    
Application No.Application TitleIssue Date
20100305097N-BENZYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES
Compounds of Formula (I)

are effective in the treatment of a microbial infection....

12/02/2010
20100193774Quinoid Compounds and Their Use in Semiconducting Matrix Materials, Electronic and Optoelectronic Structural Elements
The invention relates to quinoid compounds and their use in semiconductive matrix materials, electronic and optoelectronic structural elements....
08/05/2010
20100179137PYRIDONE COMPOUND
[Solving Means] The present inventors have conducted extensive studies on an EP4 receptor agonist, and as a result, found that a novel pyridone compound characterized in that the 1-position in the pyridone ring is substituted with a group having an acidic group such as ...
07/15/2010
20100173951NOVEL METHODS
The invention relates to the novel chemical compounds of the formula (I): (I) in free or salt form, its use in the treatment of NET and/or SERT mediated conditions, e.g., depression, vasomotor symptoms, e.g., hot flashes and other diseases or conditions mediated by NET ...
07/08/2010
20100168426NOVEL PROCESSES FOR THE PRODUCTION OF USEFUL INTERMEDIATES
The present application relates to a new process for the asymmetric production of 3-(pyridin-4-yl)-3-hydroxy-pentanoic acid derivatives, which are useful intermediates in the manufacture of compounds that are known to show antiproliferative activity....
07/01/2010
20100168175ATPENINS
The present invention relates to processes for preparing certain 2-pyridones and 2-pyridinols, to novel compounds of these two types and to their use as biologically active compounds, in particular for controlling harmful microorganisms in crop protection, in the medici...
07/01/2010
20100137376AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME
Disclosed is a plant disease control agent containing an amide compound represented by formula (1) below which has an excellent plant disease controlling effect as an active ingredient.

(In the formula, X

06/03/2010
20100089284COLORANT COMPOUND AND INK INCLUDING THE COLORANT COMPOUND
The invention provides a colorant compound represented by the following general formula (1):

wherein R1 and R2 represent independently from each other a species selected from at least on...

04/15/2010
20100076199PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS
The present invention relates to methods for the preparation of pyridone carboxylic acids for use as intermediates in the preparation of various synthetic organic compounds. The pyridone carboxylic acids can for example be used as intermediates in the production of pote...
03/25/2010
20100069440PYRIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
Disclosed are compounds of the formula I:

wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid r...

03/18/2010
20100056787CHELATING AGENTS
The present invention relates to chelating agents, in particular to chelating agents which are capable of forming complexes with paramagnetic metal ions such as iron (III) and gadolinium (III). The invention also relates to the complexes formed and their use as MRI cont...
03/04/2010
20100022779Isotopically substituted proton pump inhibitors
The invention relates to compounds of formula 1

and formula 10

and to compositions comprising these compounds and methods of treating gastrointest...

01/28/2010
20090298889PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS
The present invention herein provides a 2-pyridone derivative which has a cell adhesion-inhibitory activity and which is useful for preventing and/or treating pathema or disease conditions including, for instance, inflammations which relate to leukocytic infiltration. T...
12/03/2009
20090286818Pyridine Non-Classical Cannabinoid Compounds and Related Methods of Use

wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors....

11/19/2009
200902475882-TRIFLUOROMETHYLNICOTINAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS
The present invention relates to compounds formula I:

and pharmaceutically acceptable salts thereof, wherein R1 to R8 are as defined in the description and claims for use as HDL-choleste...

10/01/2009
20090220622USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME
The present invention relates to the use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders....
09/03/2009
20090171095PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND
A method of the invention industrially produces heterocyclic mercapto compounds useful as raw materials or intermediates in the synthesis of medicaments or pesticides, or as permanent wave agent, with a high yield and high productivity using easily available starting ma...
07/02/2009
20090156648Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
The present invention relates to stable salts of pyridoxine and α-hydroxyisocaproic acid (HICA) endowed with enhanced nutritional and/or therapeutical efficacy in respect to their individual effects and to solid compositions containing such salts, particularly suited t...
06/18/2009
20090137640POTENTIATOR FOR RADIATION THERAPY COMPRISING PYRIDINE DERIVATIVE AS ACTIVE INGREDIENT
The present invention relates to a radiotherapy enhancer that can reduce the radiation dose and adverse drug reactions when used in combination with a cancer radiotherapy. There is provided a radiotherapy enhancer comprising, as an active ingredient, a pyridine derivati...
05/28/2009
20090048276Inhibitors of Fatty Acid Synthase (Fas)
The instant invention provides for compounds which comprise substituted 3-aryl-4-hydroxyquinolin-2(1H)-ones that inhibit FAS activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting FAS activity by administeri...
02/19/2009
20080242706Fluorinated derivatives of deferiprone
The present invention relates to novel derivatives of deferiprone. In particular, the present invention relates to fluorinated derivatives of deferiprone or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, processes for the manufac...
10/02/2008
20080200520Iron Modulators
Iron modulator compounds of formula (I) are provided for treating amyloidoses wherein R1 is selected from H, C1-6 alkyl, C1-6 alkenyl, C1-6 hydroxyalkyl, C1-6 hydroxyalkenyl, R2 is selected from H, C...
08/21/2008
20080177077PROCESSES FOR THE PREPARATION OF 3-(4-(2,4-DIFLUOROBENZYLOXY)-3-BROMO-6-METHYL-2-OXOPYRIDIN-1(2H)-YL)-N,4-DIMETHYLBENZAMIDE
This invention is directed generally to processes for the preparation of compounds of Formula I:

wherein R2, R3, R4, R5, X1, X2, X3...

07/24/2008
20080027228Substituted thioacetamides
The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases. ...
01/31/2008
20080027224Camptothecin analogs and methods of preparation thereof
A compound having the formula
in racemic form, enantiomerically enriched form or enantiomerically pure form; wherein X is a radical precursor; R5 is a C1-10 alkyl group, an alkenyl group, an alkynyl group, or a benzyl group; R6
01/31/2008
200702759532-Pyridinone Derivatives, Having Hiv Inhibiting Properties
The present invention relates to 2-Pyridinone derivatives, more specifically 5-ethyl-6-methyl-2-pyridinone derivatives, according to general formula I that inhibit human immunodeficiency virus type 1 (HIV-1) replication and are therefore of interest in the treatment of ...
11/29/2007
20070270407N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
Compounds of Formula (I): are effective in the treatment of a microbial infection. ...
11/22/2007
20070249687Carbamoylpyridone Derivatives Having Inhibitory Activity Against Hiv Integrase
An object of the present invention provides a novel compound having the anti-viral activity, particularly, the HIV integrase inhibitory activity, and a drug containing the same, particularly, an anti-HIV drug.
There is provided a compound represented by the formu...
10/25/2007
20070244165Method for Identifying and Producing Effectors of Calmodulin-Dependent Peptidyl-Prolyl Cis/Trans Isomers
The present invention relates to a method for identifying and producing effectors of peptidyl-prolyl cis/trans isomerases which can be activated by calmodulin. The invention also relates to the use of the identified effectors for the production of medicaments and to scr...
10/18/2007
20070238722N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
Compounds of Formula (I): are effective in the treatment of a microbial infection. ...
10/11/2007
20070208112Use of Pyridindione Derivatives for Protecting Organic Material Against Detrimental Effects of Light
The present invention relates to the use of pyridinedione derivatives of general formula I and if appropriate their tautomers in which
  • R1 is hydrogen, optionally substituted and/or if...
09/06/2007
20070191608Process for preparing 3-aminothienopyridone derivatives
This invention provides a class of 3-amino-7H-thieno[2,3-b]pyridin-6-one derivatives, substituted in the 7-position by an aryl, heteroaryl, cycloalkyl or heterocycloalkyl moiety, and in the 2-position by a specified range of substituent groups; also provided is a proces...
08/16/2007
20070135465Fab I Inhibitor and Process for Preparing Same
A compound which is effective for inhibiting Fab I, and a method for treating a bacterial infection. ...
06/14/2007
20070010563Novel methods for the treatment of inflammatory diseases
Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine ...
01/11/2007
20060293522Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
The present invention provides novel urea mimics and analogues of Formula (I):
or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, W, and R6 are as defined herein. These compounds are se...
12/28/2006
20060173051DERIVATIVES OF 4-DEMETHYLPENCLOMEDINE, USE THEREOF AND PREPARATION THEREOF
Thiocarbonate and thiocarbamate derivatives of 4-demethylpenclomedine are provided along with pharmaceutical compositions containing them and use for treating cancer. A method for preparing the derivatives is also provided. ...
08/03/2006
20060111405O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives
The present invention relates to the o-pyridinequinone disubstituted derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives. The o-pyridinequinone disubstituted derivatives of the present in...
05/25/2006
20050271736Pyrithione compound and microcapsule using the same
A compound represented by formula (I); a multifunctional isocyanate composition, containing an adduct formed by treating the compound represented by formula (I) with a compound represented by formula (II); and a microcapsule using the multifunctional isocyanate composi...
12/08/2005
20050256089Phenyl-substituted 4-hydroxy-tetrahydropyridones
The present invention relates to novel compounds of the formula (I)
in which W, X, Y, Z, G, A, B, Q1, Q2 and D are each as defined in the disclosure, to a plurality of processes for their preparation and to their use as pesticides and he...
11/17/2005
20050245552N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
Compounds of formula (I):
are inhibitors of the enzyme Lp-PLA2 and are of use in therapy, in particular for treating atherosclerosis. In Formula I R1, R2, R3, R4, R5, R6, X and Y. ...
11/03/2005
  2    
 
Sign InRegister
Username  
Password   
forgot password?